The document outlines an AI-driven ADMET property prediction platform focusing on essential pharmacokinetic measurements such as absorption, distribution, metabolism, excretion, and toxicity, which impact drug development success rates. It details data collection methods, model implementations, and the significance of explainable AI to ensure transparency and trust in drug property predictions. Key models and algorithms, including graph-based models and message-passing neural networks, are discussed for predicting various ADMET properties from a thorough dataset.
Related topics: